This prospective open-label, non randomised ,clinical study will be conducted over 18 months at the National Institute of Homoeopathy, Kolkata, with each patient followed for six months. The study aims to evaluate the effectiveness of individualized homoeopathic treatment in improving the quality of life  of women with secondary infertility. The primary objective is to estimate the changes in Fertility quality of life of women in secondary infertility using individualised Homoeopathy medicine in 50 millesimal potency. Adults aged 18-45 years and patient diagnosed with secondary infertility and who score between 0-100 in fertility quality of life questionnaire (FertiQol), Patient who can read/understand either English, Hindi, Bengali. Patient who are willing to participate in study and giving written informed consent will be included. Patient whose husband have an abnormal semen analysis, Patient who have never conceived a pregnancy before, Patient who have already attained menopause, Patient who are pregnant ,lactating mother, taking OCPs or post hysterectomy, Patient who are taking medications for any chronic diseases, Patient who are diagnosed with life threatening diseases, systemic illness, immune –compromised states, psychiatric illness, and malignancy, Undergoing Homoeopathic treatment for any chronic disease within last 6 months will be excluded. Individualized homeopathic remedies will be selected based on repertorization (Synthesis Repertory) and Materia Medica, following Hahnemannian principles, with monthly follow-ups for six months to assess symptom changes. Treatment efficacy will be determined by comparing pre- and post-treatment of  fertility Quality of life questionaries.